Concepedia

Publication | Open Access

Placebo-controlled trial of rituximab in IgM anti-myelin–associated glycoprotein neuropathy

DOIFull Paper Access

198

Citations

25

References

2013

Year

Jean‐Marc Léger, Karine Viala, Guillaume Nicolas, Alain Créange, Jean‐Michel Vallat, Jean Pouget, Pierre Clavelou, Christophe Vial, Andreas Steck, Lucile Musset,
Neurology

Abstract

This study provides Class I evidence that rituximab is ineffective in improving ISS in patients with IgM anti-MAG demyelinating neuropathy.

References

YearCitations

Page 1